AF is once again skewing the facts and missing the point. If CTIX wants to partner these drugs after mid-stage trials are complete as they have so strongly stated very recently, do you think that they would be able to hide safety issues from BP? Of course not....now if AF is suggesting the company is simply stating they want to partner and don't really plan on it, then why bother signing confidentiality agreements and pushing so hard to make progress on all of the B clinical trials?